Walder Wyss advised Distalmotion, a globally active MedTech company based in Lausanne, throughout closing of its USD 150 million series G financing round. Revival Healthcare Capital led the funding round in question, with support from inside
Tags :Walder Wyss
Bluu Unit – a portfolio company of Triton Smaller Mid-Cap Fund II active as a provider of sustainable refrigeration, air conditioning and heating technologies – completed the acquisition of IPS Gebäudetechnik, a specialist in the same
Globally active biopharmaceutical company AstraZeneca has exercised an option to acquire obesity drug startup SixPeaks Bio. In connection with the deal, Lenz & Staehelin represented AstraZeneca, while Walder Wyss advised SixPeaks Bio and its shareholders.
Walder Wyss advised Valtronic Group, an electronics supplier specialised in developing, industrialising and manufacturing medical and diagnostic devices, on the sale of two subsidiaries with production sites in the US and Morocco to the Cicor
Walder Wyss advised Amag Leasing through placement of two senior green bond tranches in the amounting CHF 280,000,000. The bonds will be listed on the SIX Swiss Exchange. UBS Investment Bank, Zürcher Kantonalbank and
Walder Wyss advised ExcellGene and Magellan Biologics & Consulting Global, on the sale of a majority stake to private equity healthcare specialist Archimed. The deal sets to create a group covering gene transfer, cell line
Walder Wyss advised GlobalLogic, a US subsidiary of the Japanese Hitachi Group, and its lead legal advisor, the German law firm, on the acquisition of the Synvert Group from private equity fund Maxburg. The parties
Walder Wyss advised Fielmann Group and tele-ophthalmology platform Ocumeda, as the the first agreed to sell a 10% stake in Ocumenda to Zeiss Vision Care. The deal implied a total company valuation of EUR 100m, with
Walder Wyss advised Bobst Group throughout the issuance of CHF 200m senior unsecured bonds maturing in 2030 and with 2.05% coupon. The bonds in question are set to debut on the SIX Swiss Exchange. UBS, BNP Paribas,
Walder Wyss advised Groupe E on a CHF 250m bond issuance. The transaction encompasses a CHF 100m 4-year tranche with a fixed coupon of 0.750% and a CHF 150m 10-year tranche with a fixed coupon
